WASHINGTON and PARIS, June 14, 2018 /PRNewswire/ --
Following the great successof the First International NASH Day held on June 12, 2018, which has ignited enormous global enthusiasm beyond its 25 host cities and online, The NASH Education Program™ announces that:
(Logo: https://mma.prnewswire.com/media/658690/International_NASH_DAY_Logo.jpg )
(Logo: https://mma.prnewswire.com/media/658691/NASH_Education_Program_Logo.jpg )
"The world's response to International NASH Day smashed even our highest expectations - and we are deeply grateful," said Pascaline Clerc, PhD, U.S. Campaign Manager for The NASH Education Program™. "But this first convening of the world's top nonalcoholic steatohepatitis (NASH) medical and research experts, providers, patients and the public is just the first step in what we believe will be a growing global phenomenon that harnesses the world's scientific strength in one place to fully address, and beat this silent killer."
The NASH Education Program™, which has successfully launched, led and coordinated the global effort for this first-of-its-kind edition, is proud of the magnitude reached in terms of:
Early metrics on the first-ever International NASH Day's global rollout shows:
To replay the web TV program that went live for the 1st International NASH Day
Subtitles can be easily selected via the YouTube player interface (bottom right of the YouTube player screen). Seven content-rich programs are available in high definition video:
Access to photos and to media coverage review
For a first look at what happened on the 1st International NASH Day, go here.
And for an early look at media coverage, go here.
Key opinion leaders from several countries across the globe have been involved in the preparation of several local conferences, in collaboration with The NASH Education Program™. We want to commend specifically:
Official hashtags are #NASHday #MacLiver
Global supporters: non-profit organizations and benefactors
NASH, or nonalcoholic steatohepatitis, is a metabolic disease characterized by the accumulation of fat in the liver, along with inflammation and the degeneration of liver cells. The disease is associated with long-term risk of progression into diminished liver functionality, leading to non-alcoholic cirrhosis, liver insufficiency and possibly even liver cancer. It also is associated with an increased risk of cardiovascular diseases which represent the leading cause of mortality for NASH patients. The rise of NASH is connected to type 2 diabetes and obesity epidemics that are growing globally.
About The NASH Education Program™
Formed in 2017, the non-profit NASH Education Program is designed to educate and activate the patient, medical and research communities against the public health crisis that NASH presents. It is estimated that between 20 and 30% of the global population is afflicted with NAFLD, and between 5 and 12% suffer from its severe form, NASH, putting them at risk for cardiovascular events, cirrhosis or liver cancer.
The NASH Education Program™ defines and drives initiatives in collaboration with an independent scientific committee composed of four international key opinion leaders in the hepatic and metabolic disease ecosystems in the U.S. and Europe. To learn more, visit http://www.the-nash-education-program.com.
The NASH Education Program™
Pascaline Clerc - U.S. Campaign Manager, email@example.com
For the EU: Ulysse Communication, Bruno Arabian, firstname.lastname@example.org , +33-687884726
For the US: SuSiglo Media, Maritza Puello, email@example.com , +1-917-886-349
SOURCE The NASH Education Program
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All